|
LM_ID
|
Common Name
|
Systematic Name
|
Main class
|
Sub class
|
Mass
|
Formula
|
|
LMFA01030749
|
5,14,15-trihydroxy-6,8,10,12-Eicosatetraenoic acid
|
5,14,15-trihydroxy-6,8,10,12-Eicosatetraenoic acid
|
Fatty Acids and Conjugates [FA01]
|
Unsaturated fatty acids [FA0103]
|
352.22
|
C20H32O5
|
|
LMFA03000035
|
8,9-11,12-diepoxy-13-hydroxyeicosadienoic acid
|
8,9;11,12-diepoxy-13R-hydroxy-5Z,14Z-eicosadienoic acid
|
Eicosanoids [FA03]
|
Other Eicosanoids [FA0300]
|
352.22
|
C20H32O5
|
|
LMFA03000031
|
|
16R,17S,18R-trihydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Other Eicosanoids [FA0300]
|
352.22
|
C20H32O5
|
|
LMFA03000030
|
|
14S,17R,18R-trihydroxy-5Z,8Z,11Z,15E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Other Eicosanoids [FA0300]
|
352.22
|
C20H32O5
|
|
LMFA03000032
|
|
16S17S,18R-trihydroxy-5Z,8Z,11Z,14Z-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Other Eicosanoids [FA0300]
|
352.22
|
C20H32O5
|
|
LMFA03010060
|
11beta-PGE2
|
9-oxo-11S,15S-dihydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010022
|
13,14-dihydro-15-keto-PGD2
|
11,15-dioxo-9S-hydroxy-5Z-prostenoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010031
|
13,14-dihydro-15-keto-PGE2
|
9,15-dioxo-11R-hydroxy-5Z-prostenoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010146
|
15-keto-PGE1
|
9,15-dioxo-11R-hydroxy-13E-prostaenoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010026
|
15-keto-PGF2alpha
|
9S,11R-dihydroxy-15-oxo-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010102
|
15R-PGD2
|
9S,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010094
|
15R-PGE2
|
9-oxo-11R,15R-dihydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010148
|
5-trans-PGE2
|
9-oxo-11R,15S-dihydroxy-5E,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010143
|
D17 PGE1
|
9-oxo-11R,15S-dihydroxy-13E,17Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010004
|
PGD2
|
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010003
|
PGE2
|
9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010138
|
PGF3alpha
|
9S,11R,15S-trihydroxy-5Z,13E,17Z-prostatrienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010010
|
PGH2
|
9S,11R-epidioxy-15S-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010087
|
PGI2
|
6,9S-epoxy-11R,15S-dihydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010170
|
PGK1
|
9,11-dioxo-15S-hydroxy-13E-prostenoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03010101
|
delta-12-PGD2
|
9S,15S-dihydroxy-11-oxo-5Z,12E-prostadienoic acid
|
Eicosanoids [FA03]
|
Prostaglandins [FA0301]
|
352.22
|
C20H32O5
|
|
LMFA03020018
|
20-hydroxy LTB4
|
5S,12R,20-trihydroxy-6Z,8E,10E,14Z-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Leukotrienes [FA0302]
|
352.22
|
C20H32O5
|
|
LMFA03030001
|
TXA2
|
9S,11S-epoxy,15S-hydroxy-thromboxa-5Z,13E-dien-1-oic acid
|
Eicosanoids [FA03]
|
Thromboxanes [FA0303]
|
352.22
|
C20H32O5
|
|
LMFA03040008
|
13,14-dihydro-15-keto-LXA4
|
15-oxo-5S,6R-dihydroxy-7E,9E,11Z-eicosatrienoic acid
|
Eicosanoids [FA03]
|
Lipoxins [FA0304]
|
352.22
|
C20H32O5
|
|
LMFA03040010
|
15-epi-lipoxin A4
|
(5S,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid
|
Eicosanoids [FA03]
|
Lipoxins [FA0304]
|
352.22
|
C20H32O5
|
|
LMFA03040001
|
Lipoxin A4
|
5S,6R,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Lipoxins [FA0304]
|
352.22
|
C20H32O5
|
|
LMFA03040002
|
Lipoxin B4
|
5S,14R,15S-trihydroxy-6E,8Z,10E,12E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Lipoxins [FA0304]
|
352.22
|
C20H32O5
|
|
LMFA03040003
|
epi-Lipoxin A4
|
5S,6S,15S-trihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Lipoxins [FA0304]
|
352.22
|
C20H32O5
|
|
LMFA03040007
|
epi-Lipoxin B4
|
5S,14R,15R-trihydroxy-6E,8Z,10E,12E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Lipoxins [FA0304]
|
352.22
|
C20H32O5
|
|
LMFA03050025
|
13,14-Dihydro-15-oxo-lipoxin A4
|
(5R,6R,7E,9E,11Z)-5,6-dihydroxy-15-oxoicosa-7,9,11-trienoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatrienoic acids [FA0305]
|
352.22
|
C20H32O5
|
|
LMFA03060121
|
Okeanic acid A
|
11S,14R,15S-trihydroxyeicosa-5Z,8Z,12E,17Z-tetraenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306]
|
352.22
|
C20H32O5
|
|
LMFA03000029
|
|
14R,17R,18R-trihydroxy-5Z,8Z,11Z,15E-eicosatetraenoic acid
|
Eicosanoids [FA03]
|
Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306]
|
352.22
|
C20H32O5
|
|
LMFA03100025
|
12-epi-12-iso-LGD2
|
(5S,9R)-6,7-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100009
|
12-epi-12-iso-LGE2
|
(5S,9R)-7,8-seco-6,8-dioxo-12R-hydroxy-10E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100028
|
12-iso-LGD2
|
(5S,9R)-6,7-seco-6,8-dioxo-12S-hydroxy-10E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100012
|
12-iso-LGE2
|
(5S,9R)-7,8-seco-6,8-dioxo-12S-hydroxy-10E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100021
|
15-epi-15-iso-LGD2
|
(8S,12R)-9,10-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100005
|
15-epi-15-iso-LGE2
|
(8S,12R)-10,11-seco-9,11-dioxo-15R-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100024
|
15-iso-LGD2
|
(8S,12R)-9,10-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100008
|
15-iso-LGE2
|
(8S,12R)-10,11-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100033
|
5-epi-5-iso-LGD2
|
(8S,12R)-9,10-seco-9,11-dioxo-5R-hydroxy-6E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100017
|
5-epi-5-iso-LGE2
|
(8S,12R)-10,11-seco-9,11-dioxo-5R-hydroxy-6E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100036
|
5-iso-LGD2
|
(8S,12R)-9,10-seco-9,11-dioxo-5S-hydroxy-6E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100020
|
5-iso-LGE2
|
(8S,12R)-10,11-seco-9,11-dioxo-5S-hydroxy-6E,14Z-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100029
|
8-epi-8-iso-LGD2
|
(11S,15R)-12,13-seco-12,14-dioxo-8R-hydroxy-5Z,9E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100013
|
8-epi-8-iso-LGE2
|
(11S,15R)-13,14-seco-12,14-dioxo-8R-hydroxy-5Z,9E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100032
|
8-iso-LGD2
|
(11S,15R)-12,13-seco-12,14-dioxo-8S-hydroxy-5Z,9E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100016
|
8-iso-LGE2
|
(11S,15R)-13,14-seco-12,14-dioxo-8S-hydroxy-5Z,9E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100002
|
LGD2
|
(8R,12R)-9,10-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|
|
LMFA03100001
|
LGE2
|
(8R,12R)-10,11-seco-9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid
|
Eicosanoids [FA03]
|
Levuglandins [FA0310]
|
352.22
|
C20H32O5
|